Related Experiment Video

Updated: Oct 8, 2026

Deciphering the Molecular Mechanism and Function of Pore-Forming Toxins Using Leishmania major
08:17

Deciphering the Molecular Mechanism and Function of Pore-Forming Toxins Using Leishmania major

Published on: October 28, 2022

The CRK3 protein kinase is essential for cell cycle progression of Leishmania mexicana

P Hassan1, D Fergusson, K M Grant

  • 1Wellcome Centre for Molecular Parasitology, University of Glasgow, Anderson College, 56 Dumbarton Road, G11 6NU, Scotland, Glasgow, UK.

Molecular and Biochemical Parasitology
|April 11, 2001
PubMed

Insights

Leishmania mexicana CRK3 gene is essential for cell survival and controls cell cycle progression. Inhibition of CRK3 by flavopiridol arrests parasites in G2/M phase, highlighting its role in cell division.

Area of Science:

  • Molecular Biology
  • Parasitology
  • Cell Biology

Background:

  • Leishmania mexicana CRK3 gene encodes a cdc2-related protein kinase.
  • CRK3 exhibits activity towards histone H1.
  • CRK3 is essential for L. mexicana promastigote survival, as gene disruption leads to ploidy changes.

Purpose of the Study:

  • To investigate the essential role of CRK3 in Leishmania mexicana cell cycle progression.
  • To determine the specific phase of the cell cycle regulated by CRK3.
  • To assess the inhibitory effect of flavopiridol on CRK3 activity and parasite growth.

Main Methods:

  • Gene disruption attempts to assess CRK3 essentiality.
  • Use of cyclin-dependent kinase inhibitor flavopiridol.
  • Flow cytometry for cell cycle analysis (G1, S, G2/M phases).
  • In vitro kinase assays using purified CRK3his and histone H1.

Main Results:

  • CRK3 is essential for L. mexicana viability; disruption requires episomal complementation.
  • Flavopiridol inhibits CRK3his activity (IC50 = 100 nM) and L. mexicana growth.
  • Flavopiridol treatment causes cell cycle arrest at G2/M phase.
  • CRK3his activity peaks during the G2/M phase.

Conclusions:

  • CRK3 is an essential gene in L. mexicana.
  • CRK3 plays a critical role in regulating cell cycle progression at the G2/M transition.
  • CRK3 is a potential drug target for treating leishmaniasis.

More Related Videos

Preparation of Primary Acute Lymphoblastic Leukemia Cells in Different Cell Cycle Phases by Centrifugal Elutriation09:09

Preparation of Primary Acute Lymphoblastic Leukemia Cells in Different Cell Cycle Phases by Centrifugal Elutriation

Published on: November 10, 2017

Related Concept Videos

Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...